IRIS
COTUGNO, NICOLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.014
AS - Asia 3.084
EU - Europa 2.114
SA - Sud America 495
AF - Africa 66
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 1
Totale 15.781
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.875
SG - Singapore 1.493
IT - Italia 597
CN - Cina 507
BR - Brasile 401
HK - Hong Kong 352
RU - Federazione Russa 342
VN - Vietnam 247
DE - Germania 207
IE - Irlanda 207
BD - Bangladesh 143
FI - Finlandia 143
FR - Francia 119
GB - Regno Unito 116
SE - Svezia 91
JP - Giappone 89
UA - Ucraina 88
IN - India 81
CA - Canada 77
NL - Olanda 51
AT - Austria 40
AR - Argentina 39
MX - Messico 37
PL - Polonia 35
KR - Corea 31
ID - Indonesia 28
ZA - Sudafrica 27
TR - Turchia 25
ES - Italia 21
CO - Colombia 13
CZ - Repubblica Ceca 13
EC - Ecuador 13
IQ - Iraq 13
KE - Kenya 9
MA - Marocco 9
SA - Arabia Saudita 9
AU - Australia 7
JO - Giordania 7
VE - Venezuela 7
CL - Cile 6
EG - Egitto 6
KG - Kirghizistan 6
PK - Pakistan 6
PY - Paraguay 6
GR - Grecia 5
PH - Filippine 5
UZ - Uzbekistan 5
AZ - Azerbaigian 4
CH - Svizzera 4
DZ - Algeria 4
MY - Malesia 4
NP - Nepal 4
PE - Perù 4
RO - Romania 4
TH - Thailandia 4
TN - Tunisia 4
UY - Uruguay 4
AL - Albania 3
BE - Belgio 3
BG - Bulgaria 3
CR - Costa Rica 3
GH - Ghana 3
GT - Guatemala 3
HN - Honduras 3
IR - Iran 3
JM - Giamaica 3
MD - Moldavia 3
OM - Oman 3
PA - Panama 3
PT - Portogallo 3
TT - Trinidad e Tobago 3
AE - Emirati Arabi Uniti 2
CY - Cipro 2
DM - Dominica 2
HU - Ungheria 2
IL - Israele 2
LT - Lituania 2
LV - Lettonia 2
MK - Macedonia 2
PS - Palestinian Territory 2
RS - Serbia 2
TW - Taiwan 2
AI - Anguilla 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BT - Bhutan 1
BW - Botswana 1
BY - Bielorussia 1
CM - Camerun 1
DK - Danimarca 1
ET - Etiopia 1
EU - Europa 1
GE - Georgia 1
GY - Guiana 1
KW - Kuwait 1
KZ - Kazakistan 1
LB - Libano 1
MZ - Mozambico 1
NI - Nicaragua 1
NO - Norvegia 1
Totale 15.776
Salva come PNG Salva come JPEG
Città #
Wilmington 2.063
Houston 1.645
Woodbridge 1.598
Singapore 891
San Jose 445
Ashburn 381
Fairfield 354
Hong Kong 348
Chandler 344
Beijing 238
Rome 207
Dublin 183
The Dalles 156
Council Bluffs 152
Medford 143
Los Angeles 136
Seattle 136
New York 129
Santa Clara 129
Cambridge 123
Ann Arbor 95
Helsinki 93
Tokyo 86
Ho Chi Minh City 79
Buffalo 75
Lawrence 63
Munich 63
Lauterbourg 61
Jacksonville 58
Engelhard 51
Hanoi 48
Dallas 42
Milan 42
Chicago 41
Montreal 40
Nuremberg 39
San Diego 39
São Paulo 37
Moscow 31
North Bergen 30
Frankfurt am Main 29
London 29
Orem 28
Lappeenranta 26
Warsaw 26
Redondo Beach 24
St. George 23
Atlanta 22
Brooklyn 22
Pune 22
Seoul 21
Jakarta 20
Dearborn 19
Salt Lake City 19
Toronto 19
Johannesburg 18
Phoenix 18
Turin 18
Creede 17
Denver 17
San Francisco 16
Stockholm 16
Norwalk 15
Vienna 15
Chennai 14
Menlo Park 14
Da Nang 12
Naples 12
Rio de Janeiro 12
Brno 11
Amsterdam 10
Galveston 10
Mexico City 10
Poplar 10
Turku 10
Boston 9
Colorado Springs 9
Dhaka 9
Monte Vista 9
Mülheim 9
Querétaro 9
Tampa 9
Ankara 8
Bologna 8
Elk Grove Village 8
Haiphong 8
Nepi 8
Shanghai 8
Amman 7
Brasília 7
Detroit 7
Florence 7
Genoa 7
Guangzhou 7
Hyderabad 7
Hải Dương 7
Mumbai 7
Piscataway 7
Redwood City 7
Santo André 7
Totale 11.733
Salva come PNG Salva come JPEG
Nome #
A 2-month-old male with pyuria and persistent fever 511
Antibody but not memory B-cell responses are tuned-down in vertically HIV-1 infected children and young individuals being vaccinated yearly against influenza 487
Safety and immunogenicity of a monovalent MF59®-adjuvanted A/H1N1 vaccine in HIV-infected children and young adults 466
Early Highly Active Antiretroviral Therapy Enhances B-cell Longevity 457
Downfall of the current antibody correlates of influenza vaccine response in yearly vaccinated subjects: Toward qualitative rather than quantitative assays 451
Suboptimal immune reconstitution in vertically HIV infected children: a view on how HIV replication and timing of HAART initiation can impact on T and B-cell compartment 441
Premature aging of the immune system relates with increased anti-lymphocyte antibodies (ALA) after an immunization in HIV-1 infected and kidney transplanted patients 440
Premature immune senescence during HIV-1 vertical infection relates with response to influenza vaccination 430
Defective B-cell proliferation and maintenance of long-term memory in patients with chronic granulomatous disease 422
Raising awareness of non-hodgkin lymphoma in HIV-infected adolescents: Report of 2 cases in the HAART era 421
Immune reconstitution and vaccination outcome in HIV-1 infected children: present knowledge and future directions 386
Perturbation of B cell gene expression persists in HIV-infected children despite effective antiretroviral therapy and predicts H1N1 response 347
Paediatric HIV infection in the 'omics era: defining transcriptional signatures of viral control and vaccine responses 339
The EPIICAL project: an emerging global collaboration to investigate immunotherapeutic strategies in HIV-infected children 334
Impaired X-CGD T cell compartment is gp91phox-NADPH oxidase independent 219
Phenotypical T Cell Differentiation Analysis: A Diagnostic and Predictive Tool in the Study of Primary Immunodeficiencies 216
Distinct gut microbiota profile in antiretroviral therapy-treated perinatally HIV-infected patients associated with cardiac and inflammatory biomarkers 200
Artificial Intelligence Applied to in vitro Gene Expression Testing (IVIGET) to Predict Trivalent Inactivated Influenza Vaccine Immunogenicity in HIV Infected Children 195
null 192
Novel Compound Heterozygous Mutations in IL-7 Receptor α Gene in a 15-Month-Old Girl Presenting With Thrombocytopenia, Normal T Cell Count and Maternal Engraftment. 192
Waning of vaccine-induced immunity to measles in kidney transplanted children 183
Prolonged impairment of immunological memory after Anti-CD20 treatment in pediatric idiopathic nephrotic syndrome 175
The EPIICAL project: an emerging global collaboration to investigate immunotherapeutic strategies in HIV-infected children 174
Severe parainfluenza pneumonia in a case of transient hypogammalobulinemia of infancy 172
DNAM-1-chimeric receptor-engineered NK cells, combined with Nutlin-3a, more effectively fight neuroblastoma cells in vitro: a proof-of-concept study. 171
Human Immunodeficiency Virus (HIV)-Antibody repertoire estimates reservoir size and time of antiretroviral therapy initiation in virally suppressed perinatally HIV-infected children 170
How to dissect the plasticity of antigen specific immune response: a tissue perspective 162
Report from the First EPIICAL (Early-treated Perinatally HIV-infected Individuals: Improving Children's Actual Life with Novel Immunotherapeutic Strategies) General Assembly meeting, 9-11 November 2017, Rome, Italy 155
Early ART-treated perinatally HIV-infected seronegative children demonstrate distinct long-term persistence of HIV-specific T and B cell memory 152
Virological and immunological features of SARS-CoV-2-infected children who develop neutralizing antibodies 146
High mortality following early initiation of antiretroviral therapy in infants living with HIV from three African countries 135
The mission is remission: Hope for controlling HIV replication without ART in early-treated perinatally HIV-infected children 135
Partial T cell defects and expanded CD56bright NK cells in an SCID patient carrying hypomorphic mutation in the IL2RG gene 135
Clinical, Immunological, and Molecular Variability of RAG Deficiency: A Retrospective Analysis of 22 RAG Patients 134
Enhancement of neuroblastoma NK-cell-mediated lysis through NF-kB p65 subunit-induced expression of FAS and PVR, the loss of which is associated with poor patient outcome 130
Premature B-cell senescence as a consequence of chronic immune activation: Implications for vaccination of immune compromised individuals 127
Pre-vaccination immune markers predict response to BNT162b2 mRNA vaccine in vulnerable groups – The CONVERS project, report from a pediatric tertiary hospital 123
BNT162B2 mRNA COVID-19 Vaccine in Heart and Lung Transplanted Young Adults: Is an Alternative SARS-CoV-2 Immune Response Surveillance Needed? 118
OMIC Technologies and vaccine development: From the identification of vulnerable individuals to the formulation of invulnerable vaccines 113
Virological and immunological features of SARS-COV-2 infected children with distinct symptomatology 110
Epstein–Barr virus-associated smooth muscle tumor in a female with ataxia telangiectasia: a case report 106
Induction of il21 in peripheral t follicular helper cells is an indicator of influenza vaccine response in a previously vaccinated HIV-infected pediatric cohort 105
Biomarkers of vaccine safety and efficacy in vulnerable populations: Lessons from the fourth international precision vaccines conference 105
COVID-19 in children: From afterthought to unknown 104
Asymptomatic and Mild SARS-CoV-2 Infections Elicit Lower Immune Activation and Higher Specific Neutralizing Antibodies in Children Than in Adults 103
Shielding the immunocompromised: COVID-19 prevention strategies for patients with primary and secondary immunodeficiencies 102
Active prophylaxis for respiratory syncytial virus: Current knowledge and future perspectives 99
Humoral and cellular response following vaccination with the BNT162b2 mRNA COVID-19 vaccine in patients affected by primary immunodeficiencies 99
Case Report: Successful Treatment With Monoclonal Antibodies in One APDS Patient With Prolonged SARS-CoV-2 Infection Not Responsive to Previous Lines of Treatment 98
Use of dupilumab for atopic dermatitis in pediatric and young adult patients with inborn errors of immunity 98
Safety and Long-Term Immunogenicity of BNT162b2 Vaccine in Individuals with Down Syndrome 98
Development of Psychological Problems Among Adolescents During School Closures Because of the COVID-19 Lockdown Phase in Italy: A Cross-Sectional Survey 98
The Immunology of Multisystem Inflammatory Syndrome in Children with COVID-19 96
Tailored treatments in inborn errors of immunity associated with atopy (IEIs-A) with skin involvement 96
Radiosensitivity in patients affected by ARPC1B deficiency: a new disease trait? 95
Highly specific memory b cells generation after the 2nd dose of bnt162b2 vaccine compensate for the decline of serum antibodies and absence of mucosal iga 95
Evaluation of Safety and Immunogenicity of BNT162B2 mRNA COVID-19 Vaccine in IBD Pediatric Population with Distinct Immune Suppressive Regimens 94
B-cell immunity and vaccine induced antibody protection reveal the inefficacy of current vaccination schedule in infants with perinatal HIV-infection in Mozambique, Africa 94
Reduced Time to Suppression Among Neonates With HIV Initiating Antiretroviral Therapy Within 7 Days After Birth 94
T cell immune discriminants of HIV reservoir size in a pediatric cohort of perinatally infected individuals 94
Paradoxical aging in HIV: Immune senescence of B Cells is most prominent in young age 93
Multi-modal immune dynamics of pre-COVID-19 Kawasaki Disease following intravenous immunoglobulin 93
Children with perinatally acquired HIV exhibit distinct immune responses to 4CMenB vaccine 92
Quantitative Multiplexed Imaging Analysis Reveals a Strong Association between Immunogen-Specific B Cell Responses and Tonsillar Germinal Center Immune Dynamics in Children after Influenza Vaccination 92
Renal function in HIV-infected children and adolescents treated with tenofovir disoproxil fumarate and protease inhibitors 92
Similarities and differences between myocarditis following COVID-19 mRNA vaccine and multiple inflammatory syndrome with cardiac involvement in children 91
Determinants of B-Cell Compartment Hyperactivation in European Adolescents Living With Perinatally Acquired HIV-1 After Over 10 Years of Suppressive Therapy 91
The Clinical Course of SARS-CoV-2 Infection in Patients With Autoimmune Neutropenia: A Retrospective Case Series Study 90
Accelerated CD8+ T cell maturation in infants with perinatal HIV infection 89
Distinct pro-inflammatory/pro-angiogenetic signatures distinguish children with Long COVID from controls 88
Sustained aviremia despite anti-retroviral therapy non-adherence in male children after in utero HIV transmission 88
The Relationship Between Pediatric Gut Microbiota and SARS-CoV-2 Infection 88
Early and Highly Suppressive Antiretroviral Therapy Are Main Factors Associated With Low Viral Reservoir in European Perinatally HIV-Infected Children 86
Perinatally Human Immunodeficiency Virus-Infected Adolescents and Young Adults Demonstrate Distinct BNT162b2 Messenger RNA Coronavirus Disease 2019 Vaccine Immunogenicity 86
Actinomyces timonensis A Novel Pathogen to Not Overlook in Immunocompetent Children With Recurrent Cutaneous Abscesses 85
Early ART initiation during infancy preserves natural killer cells in young European adolescents living with HIV (CARMA cohort) 85
Low unspliced cell-associated HIV RNA in early treated adolescents living with HIV on long suppressive ART 84
Analytical treatment interruption in children living with HIV: position statement from the EPIICAL consortium 83
Impact of Early Antiretroviral Therapy Initiation on HIV-Specific CD4 and CD8 T Cell Function in Perinatally Infected Children 80
Ocular manifestations and viral shedding in tears of pediatric patients with coronavirus disease 2019: a preliminary report 80
The HIV-1 antibody response: a footprint of the viral reservoir in children vertically infected with HIV 79
Efficacy of CytoSorb in a Pediatric Case of Severe Multisystem Infammatory Syndrome (MIS-C): A Clinical Case Report 79
A case of purulent pericarditis caused by Haemophilus influenzae serotype b 79
Immune activation, inflammation, and non-AIDS co-morbidities in HIV-infected patients under long-term ART 78
Viral Response among Early Treated HIV Perinatally Infected Infants: Description of a Cohort in Southern Mozambique 78
Prolonged impairment of immunological memory after anti-CD20 treatment in pediatric idiopathic nephrotic syndrome: an extended follow-up 77
Relapsing myocarditis following initial recovery of post COVID-19 vaccination in two adolescent males – Case reports 77
Clinical, Virological and Immunological Subphenotypes in a Cohort of Early Treated HIV-Infected Children 76
Emerging insights into atypical B cells in pediatric chronic infectious diseases and immune system disorders: T(o)-bet on control of B-cell immune activation 75
Early inflammation as a footprint of increased mortality risk in infants living with HIV from three African countries 75
Monocytes across life span in hiv infection: Lights and shadows 74
Caregivers’ psychosocial assessment for identifying HIV-infected infants at risk of poor treatment adherence: an exploratory study in southern Mozambique 74
Exploring nasopharyngeal microbiota profile in children affected by SARS-CoV-2 infection 74
Effective early antiretroviral therapy in perinatal-HIV infection reduces subsequent plasma inflammatory profile 73
Induction of immune response after SARS-CoV-2 mRNA BNT162b2 vaccination in healthcare workers 72
Two Pediatric Cases of Multisystem Inflammatory Syndrome with Overlapping Neurological Involvement Following SARS-CoV-2 Vaccination and Unknown SARS-CoV2 Infection: The Importance of Pre-Vaccination History 71
Comprehensive and safe school strategy during COVID-19 pandemic 71
Case Report: The impact of severe cryptosporidiosis on the gut microbiota of a pediatric patient with CD40L immunodeficiency 69
Higher Troponin Levels on Admission are associated With Persistent Cardiac Magnetic Resonance Lesions in Children Developing Myocarditis After mRNA-Based COVID-19 Vaccination 67
Multisystem Inflammatory Syndrome in Children in Western Countries? Decreasing Incidence as the Pandemic Progresses?: An Observational Multicenter International Cross-sectional Study 66
Totale 15.279
Salva come PNG Salva come JPEG
Categoria #
all - tutte 63.674
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 63.674
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022827 28 82 46 21 108 50 8 19 172 34 65 194
2022/2023948 73 84 14 94 76 197 151 51 122 3 53 30
2023/2024539 33 92 25 4 53 153 35 15 14 23 31 61
2024/20252.547 70 476 244 166 52 221 161 179 261 292 236 189
2025/20264.891 400 261 493 419 402 191 714 564 487 407 309 244
2026/20275 5 0 0 0 0 0 0 0 0 0 0 0
Totale 16.174